Fundraising Fox
/Companies
Sign in

MucoLife Therapeutics

1 known investors

Find your way into MucoLife Therapeutics

Sign up to see every warm intro you have to MucoLife Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the MucoLife Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

MucoLife Therapeutics develops treatments for pulmonary mucus obstruction associated with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Its lead product is a mucus modulator designed to dissolve mucus plugs obstructing the airways.

BiotechHealthtech

Founders & leadership

TPThaher Pelaseyed
Thaher PelaseyedCo-founder & Chief Executive OfficerThaher Pelaseyed is co-founder and CEO of MucoLife Therapeutics, a company developing mucus-modulating treatments for COPD and cystic fibrosis. He has over 20 years of research experience in cell and mucin biology, including work at the Mucin Biology Group at University of Gothenburg, where his research has focused on transmembrane mucins and epithelial cell defense mechanisms.
GCGunnar C. Hansson
Gunnar C. HanssonCo-founder & Chief Scientific OfficerCo-founder & Chief Scientific Officer at Mucolife
KJKicki Johansson
Kicki JohanssonChief Development OfficerChief Development Officer at Mucolife
MKMaarten Kraan
Maarten KraanChief Clinical OfficerChief Clinical Officer at Mucolife
JSJim Shaffer
Jim ShafferChief Business OfficerChief Business Officer at Mucolife

Investors · 1

Frequently asked questions

What does MucoLife Therapeutics do?
MucoLife Therapeutics develops treatments for pulmonary mucus obstruction associated with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Its lead product is a mucus modulator designed to dissolve mucus plugs obstructing the airways.
Who founded MucoLife Therapeutics?
MucoLife Therapeutics was founded by Thaher Pelaseyed, Gunnar C. Hansson.
Who are MucoLife Therapeutics's investors?
MucoLife Therapeutics's investors include Health Wildcatters.